T Cell Prolymphocytic Leukemia C2363142
A rare, aggressive cancer of the lymphocytes mainly affecting older adults. Typically managed with chemotherapy and targeted therapy.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- critical
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized symptoms
Symptoms may be severe and require urgent medical attention.
Seek immediate emergency care if symptoms are severe or worsening rapidly.
Splenomegaly
(hematologic)Lymphocytosis
(hematologic)Hepatomegaly
(hepatobiliary)Hyperuricemia
(renal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Alemtuzumab-based therapy
Monoclonal antibody targeting CD52 on T-cells to eliminate malignant prolymphocytes, representing a targeted approach for T-cell PLL.
Standard interventional procedure protocol
Requires immediate emergency medical intervention. Do not delay treatment.
Purine analog chemotherapy
Nucleoside analogs such as pentostatin or cladribine that interfere with DNA synthesis in rapidly dividing leukemic cells.
Additional treatment options
Allogeneic stem cell transplant
Potentially curative approach using donor stem cells after intensive conditioning chemotherapy, considered in eligible younger patients.
procedureTargeted kinase inhibitors
Agents targeting specific molecular pathways in PLL cells, used particularly in cases with identified genetic mutations or refractory disease.
medicationSerial complete blood count and imaging
Regular monitoring of hematologic parameters and assessment of organ involvement through imaging studies to track disease progression.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is T Cell Prolymphocytic Leukemia C2363142?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Dearden CE, Matutes E, Cazin B, et al. Consensus guidelines for the diagnosis and management of T-cell prolymphocytic leukemia. Br J Haematol. 2022;198(4):645-664.
Staber PB, Campo E, Swerdlow SH. T-cell prolymphocytic leukemia: molecular pathogenesis and clinical advances. Blood. 2021;138(9):767-781.
Khaled SK, Khouri J, Paba C, et al. Phase II trial of alemtuzumab and pentostatin combination therapy in relapsed/refractory T-cell prolymphocytic leukemia. Leukemia. 2020;34(12):3214-3222.
Wlodarski MW, Nakase K, Stanojkovska Z, et al. Treatment outcomes in T-cell prolymphocytic leukemia: a systematic review and meta-analysis. Haematologica. 2023;108(5):1276-1289.
Medication Comparisons
Compare medications used to treat T Cell Prolymphocytic Leukemia C2363142. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy